U.S. markets open in 5 hours 24 minutes

Smith & Nephew plc (SNN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
26.35+0.29 (+1.11%)
At close: 04:00PM EDT
26.35 0.00 (0.00%)
After hours: 04:32PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close26.06
Bid0.00 x 900
Ask0.00 x 800
Day's Range26.29 - 26.49
52 Week Range24.80 - 39.19
Avg. Volume856,788
Market Cap11.57B
Beta (5Y Monthly)0.40
PE Ratio (TTM)23.32
Earnings DateN/A
Forward Dividend & Yield0.75 (2.88%)
Ex-Dividend DateMar 31, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-0% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SNN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Smith & Nephew SNATS, Inc.
    Analyst Report: Smith & Nephew plcSmith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more